Gemini bioproducts:1110293 [16-027103]

Ended Purchase Order Awarded Last action

Contract number
HHSN261201600224P
Awardee
Awarding agency
Obligated
$18,187

Award facts

Contract value 100% obligated
$18,187.45 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Broderick, CA 95605, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$63
Original award $18,250

About this award

The National Cancer Institute awarded a purchase order to Gemini Bioproducts LLC for $18,187.45 on March 2, 2016, under a total small business set-aside. The order is firm fixed-price and calls for completion by March 7, 2016. Work is performed in Broderick, California. The purchase order covers cell culture products, media, sera, and related scientific reagents for biomedical research.

Quick answers

Who was awarded contract HHSN261201600224P?

HHSN261201600224P was awarded to Gemini Bioproducts LLC by National Cancer Institute (National Institutes of Health) on March 2, 2016.

How much is contract HHSN261201600224P worth?

The government has obligated $18,187 on HHSN261201600224P.

Was contract HHSN261201600224P competed?

The extent of competition for HHSN261201600224P was competed under sap. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award